Login / Signup

Impact of molecular subtype and race on HR+, HER2- breast cancer survival.

Sonya A ReidDiane HaddadAnn TezakAnne WeidnerXuefeng WangBrian MautzJaleesa MooreSydney CadizYuwei ZhuWei ZhengIngrid A MayerXiao-Ou ShuTuya Pal
Published in: Breast cancer research and treatment (2021)
Molecular subtype classification highlights racial disparities in PAM50 subtype distribution among women with HR+, HER2- breast cancer. Among women with HR+, HER2- breast cancer, racial survival disparities are ameliorated after adjusting for molecular subtype.
Keyphrases
  • machine learning
  • single molecule
  • deep learning
  • african american
  • healthcare
  • free survival
  • breast cancer risk